The major dierentiation products of maturing keratinocytes contain AP-1 regulatory motifs, and AP-1 DNA binding activity increases in cultured keratinocytes induced to dierentiate by calcium. Here, we have analysed AP-1 transcriptional activity in mouse keratinocytes treated with calcium and 12-O-tetradecanoyl phorbol-13-acetate (TPA), two agents that induce terminal dierentiation of keratinocytes with dierent phenotypic consequences. Reporter constructs representing multimers of AP-1 sequences found in keratinocyte marker genes demonstrated that the calcium-induced AP-1 DNA binding activity does not correlate with transcriptional activation. Moreover, expression from active subunits of the pro®laggrin and spr 1 promoters increased in calcium-treated keratinocytes when the AP-1 sites were disrupted, indicating that AP-1 may negatively regulate certain promoters in these cells. In contrast, AP-1 reporter activity was increased in keratinocytes treated with TPA. This induction was dependent upon the expression of c-Fos since AP-1 transcriptional activity was not increased in TPA-treated keratinocytes derived from c-fos null mice. Analysis of AP-1 protein expression in calcium-and TPA-treated keratinocytes demonstrated that only TPA increased the expression of c-Jun, while Jun B and Jun D were induced by both of these agents. c-Fos was expressed only in TPA treated keratinocytes, Fra-2 was expressed only in calcium-treated cells, and Fra-1 was expressed in both. Exogenous expression of Fra-2 repressed AP-1 transcriptional activity in TPA-treated keratinocytes, while c-Fos expression activated the AP-1 sequence in calcium-treated keratinocytes. These data indicate that Fra-2 and c-Fos play opposing roles in regulating AP-1 activity in keratinocytes and that multiple inducerdependent regulatory pathways may exist for the expression of keratinocyte dierentiation markers.
Introduction
Epidermal dierentiation is characterized by the induction and repression of marker genes that de®ne speci®c stages of keratinocyte maturation (reviewed in Yuspa, 1994) . In mouse and human skin, the proliferative basal layer consists of cells expressing transcripts encoding keratins 5 and 14. As keratinocytes withdraw from the cell cycle, they undergo spinous dierentiation, characterized by the downregulation of keratins 5 and 14, and the induction of transcripts encoding keratins 1 and 10 (K1 and K10) (Roop et al., 1988; Stoler et al., 1988; Fuchs, 1990) . Transcripts encoding K1 and K10 are subsequently down-regulated in the granular layer, where the late marker genes loricrin and ®laggrin are induced (Roop et al., 1988; Fuchs, 1990) . In addition, keratinocyte transglutaminases are activated in the granular layer to catalyze the formation of corni®ed envelopes (reviewed in Polakowska and Goldsmith, 1991) , insoluble structures composed of precursor proteins involucrin (Rice and Green, 1979) , small proline rich (spr) proteins (Kartasova et al., 1987; Marvin et al., 1992) , loricrin (Mehrel et al., 1990) , and other components (Steinert and Merekov, 1995) .
Many of the changes in marker gene expression that occur in the dierentiating epidermis can be recapitulated in mouse keratinocytes maintained in vitro by increasing the level of calcium in the medium from 0.05 to 0.12 mM (Yuspa et al., 1989) . For example, under these conditions transcripts encoding keratins 1 and 10 are induced within 24 h after raising the calcium concentration. By 48 h, these transcripts are downregulated while those encoding the late markers loricrin, ®laggrin, spr 1 and transglutaminase are induced. Terminal dierentiation of mouse keratinocytes can also be induced by 12-O-tetradecanoyl phorbol-13-acetate (TPA) (Yuspa et al., 1982; Parkinson et al., 1984) . TPA-treated keratinocytes in vitro express high levels of the late markers loricrin and ®laggrin (Dlugosz and Yuspa, 1993) , produce activated transglutaminase (Lichti and Yuspa, 1988) , and undergo an ecient process of corni®cation (Yuspa et al., 1982) . Yet, these cells do not express the early marker genes K1 and K10 seen in calcium-treated cells (Roop et al., 1987; Toftgard et al., 1985) . Analysis of cellular proteins produced by calcium-and TPA-treated keratinocytes indicated similarities and dierences in protein expression and phosphorylation patterns in response to these agents, indicating overlap and divergence in the pathways by which calcium and TPA induce terminal dierentiation (Wirth et al., 1987) .
The changes in marker gene expression that occur in dierentiating keratinocytes in vitro are dependent upon the activation of protein kinase C (PKC) Yuspa, 1993, 1994) . Since the AP-1 transcription factor complex is a well-de®ned nuclear target of PKC activation (reviewed in Hill and Treisman, 1995) , our current studies are focused upon understanding the role of AP-1 in the regulation of events related to keratinocyte dierentiation. The AP-1 transcription factor complex is composed of heterodimers formed between members of the Jun and Fos families that bind to DNA in a sequence-speci®c manner (reviewed in Curran and Franza, 1988; Angel and Karin, 1991) . The Jun family consists of three proteins (c-Jun, Jun B and Jun D) while the Fos family is composed of four proteins (c-Fos, Fos B, Fra-1 and Fra-2) that require heterodimerization with Jun proteins or other members of the bZIP superfamily of DNA binding proteins (Johnson and McKnight, 1989) to bind to DNA. The Fos proteins contribute distinct functions towards the activity of the AP-1 heterodimer. For example, c-Fos can both activate and repress transcription (Gius et al., 1990) , the full-length Fos B is a transcriptional activator (Dobrazanski et al., 1991) and a naturally occurring short form of Fos B inhibits AP-1 transactivation (Yen et al., 1991; Nakabeppu and Nathans, 1991) . The Fos-related antigens Fra-1 and Fra-2 lack functional transactivation domains and are poor transcriptional activators (Gius et al., 1990; Yoshioka et al., 1995; Suzuki et al., 1991) .
The consensus AP-1 DNA binding site, also known as the TPA-responsive element (TRE) (Angel et al., 1987) , is prevalent in regulatory positions of many genes expressed during keratinocyte dierentiation, suggesting that AP-1 may play an important role in controlling gene expression during this process. AP-1 DNA binding sites have been shown to play an important role in cell-and tissue-speci®c expression of the loricrin (DiSepio et al., 1995) , involucrin (Crish et al., 1993; Welter et al., 1995) , keratin 5 (Casatorres et al., 1994) and keratin 1 (Rothnagel et al., 1993; Lu et al., 1994) genes in vitro and in vivo. Additional in vitro studies indicate that AP-1 proteins largely play a positive role in regulating the expression of keratinocyte genes that harbor AP-1 sites (Navarro et al., 1995; Yamada et al., 1994; Takahashi and Iizuka, 1993; DiSepio et al., 1995; Bernerd et al., 1993; Oshima et al., 1990) , although in vivo studies will ultimately be required to provide a de®nitive demonstration of the role of AP-1 in regulating gene expression in the epidermis. Since epidermal genes containing AP-1 binding sites are both induced and suppressed during the dierentiation program, the possibility exists that the AP-1 transcription factor complex may contribute both positive and negative regulatory eects during this process.
We have shown that PKC-dependent AP-1 DNA binding activity increases in keratinocytes induced to dierentiate by the addition of calcium to the medium (Rutberg et al., 1996) . The levels of AP-1 DNA binding activity peak late in the dierentiation program, and correlate with a PKC-dependent increase in the expression of Fra-2, Jun B and Jun D. Immunostaining with antibodies against AP-1 proteins indicated that Fra-2 and Jun B are localized in the granular layer of mouse epidermis, supporting that these transcription factors are important during the late stages of keratinocyte dierentiation. The present study demonstrates that the calcium-induced increase in AP-1 DNA binding activity fails to result in transcriptional activation and may negatively regulate AP-1 dependent gene expression in keratinocytes. TPA also causes an increase in AP-1 DNA binding activity in keratinocytes, but in contrast to the eects of calcium, TPA enhances the expression of AP-1 regulated reporter genes. The functional dierences between the AP-1 complexes induced by calcium or TPA can be attributed to dierences in the composition of the AP-1 DNA binding complex that is formed in the presence of each stimulus.
Results

TPA and calcium induce AP-1 DNA binding activity
Since PKC activation is a necessary event during keratinocyte dierentiation and AP-1 is a known nuclear target of protein kinase C activity, we compared the levels of AP-1 DNA binding activity in keratinocytes treated with calcium and TPA, two PKC activators that induce keratinocyte dierentiation in vitro (Denning et al., 1995a; Yuspa et al., 1982 Yuspa et al., , 1989 Parkinson et al., 1984) . A comparison of the AP-1 DNA binding complexes formed in TPA and calcium treated keratinocytes indicated that while AP-1 DNA binding activity was induced under both conditions, the binding complexes diered in migration pattern and intensity (Figure 1 ). Nuclear extracts prepared from keratinocytes maintained for 48 h in 0.12 mM calcium contained a large and intense, slowly-migrating AP-1 DNA binding complex. In contrast, the TPAinducible AP-1 DNA binding complex was more diuse, and appeared to consist of multiple complexes that formed very close to one another, producing a smear on the gel. These complexes contrast with the very weak AP-1 DNA binding activity observed in basal keratinocytes (maintained in 0.05 mM calcium). The complexes formed under each of these conditions were speci®c for the AP-1 site, as determined by competition with 100-fold excess speci®c (AP-1) and non-speci®c (SP-1) DNA sequences. Previous data indicated that the calcium-inducible AP-1 DNA binding complex consists of c-Jun, Jun B, Jun D, Fra-1 and Fra-2 (Rutberg et al., 1996) ; supershift analysis indicated that the AP-1 DNA binding complex in TPA-treated keratinocytes consisted of c-Jun, Jun B and Jun D, c-Fos and Fra-1 (Figure 2 ).
Calcium-induced keratinocyte dierentiation correlates with decreased AP-1 transcriptional activity
To assess the functional role of the calcium-induced increase in AP-1 DNA binding, we evaluated the transcriptional activity of a multimer of the consensus AP-1 target binding squence (56TRE-CAT) (Angel et al., 1987) in basal and dierentiating keratinocytes. In addition, AP-1 sequences from the calcium-responsive element of the human keratin 1 gene (gaTGATTCAct) (Hu et al., 1993; Rothnagel et al., 1993) , from position 777 of the 5' region of the human pro®laggrin promoter (gaTGAATCAct) (Markova et al., 1993) , and from one of the AP-1 sites (gtTGACTAAcg) at position 7288 of the 5' noncoding region of the human involucrin gene (LopezBayghen et al., 1996) were also cloned as 56 multimers into the same pBLCAT2 reporter construct (Figure 3a ). Supershift analysis indicated that the composition of the AP-1 complexes bound to these sequences in 0.12 mM calcium was the same (not shown). The AP-1 site in the 5' region of the loricrin gene is identical to the consensus AP-1 sequence in the 56 TRE vector, and is referred to as the loricrin AP-1 site in this ®gure.
A modest time-dependent decrease in AP-1 transcriptional activity was seen with three of the four AP-1 reporter vectors in keratinocytes induced to dierentiate by the addition of calcium to the medium (loricrin, HK1 and involucrin), indicating that calciuminduced keratinocyte dierentiation in vitro correlates with a decrease in AP-1 transcriptional activity ( Figure  3b ). While the pro®laggrin AP-1 site remained unaected by the addition of calcium to the medium, none of the AP-1 sequences tested demonstrated increased activity in response to calcium. Transfected cells harvested 54 ± 60 h after the addition of calcium exhibited similar levels of AP-1 activity as those collected at 48 h (data not shown).
AP-1 negatively regulates the pro®laggrin and spr 1 promoters in dierentiating keratinocytes
Because the analysis of isolated sequence elements cloned in front of a reporter gene can sometimes oer an incomplete picture of transcription factor activity, we examined whether the apparent lack of activation potential of the AP-1 transcription complex in calcium-treated keratinocytes was relevant to the expression of the pro®laggrin and spr 1 genes in dierentiating keratinocytes. Promoter constructs containing the ®rst 116 base pairs of the pro®laggrin promoter were generated in which the AP-1 site at position 777 was maintained in the wild-type con®guration (7116 wild-type) or deleted (7116 mutant, Figure 4a , upper panel). The activity of these constructs in basal and dierentiating keratinocytes was compared with that of the core promoter containing the ®rst 59 base pairs of the promoter alone (759 CAT). As shown in Figure 4b , the activity of the mutant construct was similar to that of the wild-type in basal keratinocytes. Upon addition of The loricrin construct is identical to the 56TRE-CAT vector described by (Angel et al., 1987) . (b) Primary mouse keratinocytes were transfected with the vectors described in Figure 3a . Cells were maintained in 0.05 mM calcium for 24 h, or in 0.12 mM calcium for 24 and 48 h. Values +s.e.m. are expressed relative to the activity of the parent pBLCAT vector alone. These data were replicated in three separate experiments calcium to the medium, the activity of the wild-type construct increased ®vefold within 24 h while the absence of the AP-1 site at position 777 resulted in a tenfold increase in CAT activity over that seen in basal cells. These results suggest that the factors binding to the AP-1 site on the pro®laggrin promoter interfere with positive regulation or negatively regulate this portion of the pro®laggrin promoter in keratinocytes induced to dierentiate by calcium. The activity of the mutant construct remained approximately fourfold higher than that of the wild-type reporter 60 h after the addition of calcium, a time when the activity of the wild-type and 759 constructs had decreased.
Promoter constructs from a second keratinocyte gene were used to support the ®ndings obtained with the pro®laggrin reporter constructs. A 66 base pair region of the spr 1 promoter, which contains two AP-1 sites in close proximity, was used to generate wildtype and mutant constructs in which each of the AP-1 sequences was mutated alone or in combination, as described in Reddy et al., 1996 (see also Figure 4a , lower panel). The 5' AP-1 DNA binding site consists of a consensus AP-1 binding sequence 5'-gtTGAGTCAac-3' while the 3' site bears the sequence 5'-ggTGAATCAca-3'. As shown in Figure 4c , the activity of the 5' mutant (TtcGTCA) was 2.5-fold greater than the wild-type construct in basal keratinocytes and remained 2.5-fold greater than wild-type in dierentiated keratinocytes 24 and 60 h after the addition of calcium to the medium. Thus, this site appears to act as a repressor of gene expression in both basal and dierentiating cells. In contrast, the 3' mutant (TaAATCA) demonstrated decreased activity compared to the wild-type construct in basal keratinocytes, suggesting that this AP-1 site enhances expression of this region of the spr 1 promoter. Moreover, the 3' mutant was calcium inducible, suggesting that the 3' AP-1 site is not required for calcium inducibility of this portion of the spr 1 promoter. The activity of the double mutant appeared to be intermediate between that of the single mutants. These results indicate that (1) negative regulation by AP-1 occurs in a sequence-speci®c manner, and (2) that the function (positive or negative) of a given AP-1 DNA binding sequence is likely to depend upon the context of the promoter on which it is found. This is inferred from the fact that the 3' AP-1 DNA binding sequence on the spr 1 promoter is identical to that on the pro®laggrin construct, yet alteration of this sequence yielded dierent results within the two promoters tested. These dierences may also re¯ect consequences of mutating (spr 1) or deleting (pro®laggrin) the AP-1 site rather than functional dierences between the identical AP-1 sites on the two dierent promoters.
Calcium and TPA have opposing eects on AP-1 transcriptional activity in keratinocytes
To examine whether the increase in AP-1 DNA binding activity in response to TPA-treatment of keratinocytes serves a similar regulatory function as that induced by calcium, keratinocytes transfected with the 56 TRE-CAT reporter (loricrin AP-1 site) were treated with 162 nM TPA or 0.12 mM calcium and analysed 24 and 48 h later, respectively. A comparison of the eect of calcium and TPA on AP-1-CAT activity in these cells indicated that, in contrast to the decrease in AP-1 dependent activity in calcium-treated cells, TPA treatment increased AP-1 transcriptional activity a b c Figure 4 Disruption of AP-1 regulatory sequences increases the activity of the pro®laggrin and spr 1 promoters in dierentiating keratinocytes. (a) The pro®laggrin and spr 1 promoter constructs used in this study as described in (Jang et al., 1996) and (Reddy et al., 1996) . (b) Primary keratinocytes were transfected with the 7116 wild-type AP-1, 7116 mutant AP-1, and 759 core pro®laggrin promoter constructs described in a. Cells were maintained in 0.05 mM calcium for 24 h, or in 0.12 mM calcium for 24 or 60 h. Values reported represent mean+s.e.m. for triplicate dishes from a representative experiment. (c) Primary keratinocytes were transfected with a 66 base pair region of the spr 1 promoter in the wild-type con®guration, or in which the 3' and 5' AP-1 sequences have been mutated alone or together (double mutant). Cells were maintained in 0.05 for 24 h or 0.12 mM calcium for 24 or 60 h. Values reported represent mean+s.e.m. for triplicate dishes from a representative experiment threefold (Figure 5a ). This observation held with each of the 56 multimers of the AP-1 sequence described in Figure 3a , all of which were induced 2 ± 4-fold by the addition of TPA to the medium and similar levels of induction were observed in cells maintained in 8% and 0.5% serum (data not shown). The simultaneous addition of calcium and TPA to the cells resulted in levels of AP-1-CAT activity that were intermediate between those in 0.12 mM calcium and 162 nM TPA (data not shown). TPA-inducible AP-1-CAT activity has been attributed to the induction, and/or modification of c-Fos and c-Jun (Greenberg and Zi, 1984; Lamph et al., 1988; Devary et al., 1991) . To establish whether c-Fos plays a role in TPA-mediated AP-1-CAT activity in keratinocytes, AP-1 transcriptional activity was evaluated in c-fos null keratinocytes treated with TPA. In contrast to the increase in AP-1-CAT activity caused by TPA in wild-type cells, no TPA-related induction of AP-1-CAT activity was seen in c-fos null keratinocytes, indicating that TPAmediated activation of AP-1-CAT activity in keratinocytes is dependent upon the presence of c-Fos ( Figure  5b ).
The pro®laggrin promoter constructs used in Figure  4b were evaluated in TPA-treated keratinocytes to establish whether their activities would be altered under conditions where c-Fos is expressed. As shown in Figure 5c , the wild-type reporter was induced 2.5-fold in the presence of TPA supporting the increased expression of the pro®laggrin message seen in TPA treated keratinocytes (Dlugosz and Yuspa, 1993) . In contrast to the increased activity of the AP-1 mutant construct in calcium-treated cells, the activity of the mutant promoter was not increased upon TPA treatment. Thus, AP-1 proteins appear to play a critical role in activating this portion of the profilaggrin promoter in TPA-treated keratinocytes.
c-Fos and Fra-2 are dierentially regulated by calcium and TPA in keratinocytes
The opposing functional roles of the AP-1 DNA binding activity induced by calcium and TPA could be due to dierences in the composition of the AP-1 complex induced by each stimulus. To evaluate the dierences in AP-1 protein expression in response to calcium and TPA, we performed Western blot analysis using antibodies speci®c for known members of the AP-1 family (Figure 6 ). TPA caused an increase in the levels of c-Jun expression. This is in contrast to the slightly decreased levels of c-Jun in calcium-treated keratinocytes as shown here and previously (Rutberg et al., 1996) . In contrast, Jun B and Jun D were induced to a similar extent by calcium and TPA. Additional lower molecular weight Jun B-reactive bands that are partially sensitive to alkaline phosphatase (data not shown) were detected with antibodies against Jun B in TPA-treated cells, indicating that potential dierences in post-translational modi®cation of this protein may exist between calcium and TPA treated keratinocytes. The appearance of additional lower molecular weight Jun B-reactive bands in response to TPA treatment has been described previously (Au et al., 1994) . The 41 kDa Jun D-reactive band observed in calcium and TPA-treated cells is a naturally occurring truncated form of the protein (Rezzonico et al., 1995) . With regard to the Fos family proteins, c-Fos was induced only in TPA treated keratinocytes: no c-Fos protein was detected in keratinocytes maintained in 0.05 mM or 0.12 mM calcium, consistent with the absence of a phenotype related to c-fos de®ciency in keratinocytes in vitro (Rutberg et al., 1996) or in newborn skin from cfos null mice (Saez et al., 1995) . In contrast, Fra-2 was expressed exclusively in keratinocytes induced to dierentiate by the addition of calcium to the medium. The 48 kDa Fra-2 reactive band in Figure 6 represents the phosphorylated form of Fra-2 (Gruda et al., 1994) . The 43 kDa unphosphorylated form of Fra-1 was expressed at equal levels in basal keratinocytes and in keratinocytes treated with calcium or TPA. TPA 
c-Fos and Fra-2 have dierent eects on AP-1 transcriptional activity in keratinocytes
In order to determine the eects of increasing the expression levels of c-Fos and Fra-2 on the levels of AP-1-CAT activity in TPA-treated keratinocytes, expression vectors encoding mouse Fra-2, c-Fos and Jun B cDNAs were co-transfected (together and separately) with the 56 TRE-CAT reporter construct into keratinocytes which were then treated with TPA ( Figure 7a ). Jun B was chosen as an appropriate dimerization partner for c-Fos and Fra-2 since Jun B expression was increased in both calcium and TPAtreated cells (Figure 6 ). The ability of the expression vectors to produce high levels of protein within 24 h was con®rmed through Western blot analysis of nuclear extracts prepared from transfected cells (not shown). This approach indicated that neither exogenous Jun B nor c-Fos alone were able to increase the levels of AP-1-CAT activity above that seen in TPAtreated control cells transfected with the parent constructs. However, the combination of Jun B and c-Fos expression vectors increased AP-1-CAT activity above that of the controls indicating that the c-Fos/Jun B heterodimer formed by the forced expression of these two factors is a transcriptionally active complex. In contrast, Fra-2 alone, or expressed in combination with Jun B, negatively regulated AP-1-CAT activity in TPA treated keratinocytes indicating that Fra-2 is a powerful negative transcriptional regulator in these cells. These data support that dierences in the expression patterns of c-Fos and Fra-2 may explain the opposite levels of AP-1-dependent transactivation in keratinocytes treated with calcium or TPA.
To establish whether the reduced levels of AP-1-dependent transcriptional activity measured in differentiating keratinocytes could be elevated by the expression of c-Fos alone, c-Fos and Fra-2 expression vectors were co-transfected with the 56TRE-CAT reporter into basal keratinocytes which were then 
Discussion
In this study we demonstrate that the opposing eects of calcium and TPA on the regulation of AP-1 transcriptional activity in dierentiating keratinocytes correlate with dierential expression of Fra-2 and cFos. The exogenous expression of Fra-2 alone, or in conjunction with Jun B, results in negative regulation of AP-1 reporter constructs indicating that the Fra-2/ Jun B heterodimer may be responsible for the decreased AP-1 transcriptional activity observed in calcium-treated keratinocytes. In contrast, TPA treatment enhances AP-1 transcriptional activity in keratinocytes, correlating with the induction of c-Fos expression and the ability of c-Fos to bind to the AP-1 target sequence. Furthermore, exogenous expression of c-Fos alone is sucient to elevate AP-1 transcriptional activity in calcium-treated keratinocytes. Together, these data indicate that Fra-2 and c-Fos have opposite eects on AP-1 transcriptional activity in keratinocytes.
Multimers of the AP-1 target sequence linked to the CAT reporter gene demonstrated a time-dependent decrease in transcriptional activity in keratinocytes induced to dierentiate by calcium. This decrease occurs in concert with the formation of a strong AP-1 DNA binding complex that peaks in intensity 36 ± 48 h after the addition of calcium to the medium (Rutberg et al., 1996) suggesting that this complex may serve to negatively regulate transcription in differentiating keratinocytes. The use of wild-type and mutated forms of portions of the pro®laggrin and spr 1 promoters support this notion since disruption of AP-1 sites on these constructs lead to increased activity of the reporters in calcium-treated keratinocytes. Assays utilizing the spr 1 promoter constructs indicated that negative transcriptional regulation mediated by AP-1 occurs in a sequence speci®c manner, since of the two AP-1 sites present on the construct, only the 5' consensus AP-1 site exhibited this eect. Our data also suggest that the regulatory eects imposed by a given AP-1 sequence may be context-dependent since the 3' AP-1 sequence on the spr 1 promoter and the AP-1 site on the pro®laggrin promoter construct are identical in sequence, but appear to mediate opposite regulatory eects within the dierent promoter constructs. In a similar fashion, AP-1 proteins have been shown to bind to a region of the involucrin promoter that functions as a transcriptional silencer in calcium-treated human keratinocytes maintained in the absence of EGF and bovine pituitary extract while other AP-1 sites on the promoter acted as transcriptional activators in these cells (Lopez-Bayghen et al., 1996) . Together, these data support that location-or sequence-speci®c factors may in¯uence the activity of AP-1 DNA binding proteins within the context of a particular promoter region.
It is possible that negative regulation exerted by AP-1 proteins requires interactions with factors binding to nearby sites on the DNA that dier between the regulatory regions of dierent genes, or that variations in the¯anking sequences surrounding a given AP-1 site favor the binding of particular AP-1 heterodimers with dierent transcriptional potential. The mechanism by which speci®c AP-1 proteins (such as Fra-2) decrease the transcriptional activity of the pro®laggrin and spr 1 promoters in dierentiating keratinocytes may involve squelching the activities of positive-acting AP-1 factors, or blocking the function of unrelated transcriptional activators through stearic hindrance at the AP-1 target site. An Ets binding site overlaps with the AP-1 DNA binding sequence at position 777 of the pro®laggrin promoter (Jang et al., 1996) . It is possible that the apparent negative regulation of this site in differentiating keratinocytes results from interactions between AP-1 and Ets transcription factors. Alternatively, negative regulation by AP-1 may re¯ect a combination of changes in the relative expression levels, DNA binding activity and/or phosphorylation status of particular AP-1 proteins, all factors that contribute to the levels of AP-1 transcriptional activity. Since our data is compatible with these and other mechanisms, further studies will be required to unravel how AP-1 proteins negatively regulate epidermal-speci®c genes.
Our work shows that the induction of the portion of the pro®laggrin promoter used here occurs through dierent mechanisms in response to calcium and TPA. Although both calcium and TPA induced the pro®laggrin promoter construct to a similar extent, the calcium-mediated induction of the promoter occurred independently of AP-1, perhaps through the action of other transcriptional regulators with binding sites on this region of the promoter (Jang et al., 1996) . In contrast, the induction of the pro®laggrin promoter construct in TPA-treated cells appeared to be entirely dependent upon an intact AP-1 site. It is interesting that the silencing eects of the AP-1 sequences on the involucrin promoter in calcium-treated human keratinocytes described above (Lopez-Bayghen et al., 1996) were not apparent in TPA-treated human keratinocytes (Welter et al., 1995) . It is likely that c-Fos is induced under these conditions, and that the silencing eects of other AP-1 family members are masked by the presence of c-Fos.
In light of these observations, it becomes clear that the conditions under which keratinocytes are maintained in culture signi®cantly in¯uence the expression of speci®c AP-1 family members resulting in divergent eects on gene transcription. The lack of constitutive c-Fos expression in primary mouse keratinocytes has allowed us to analyse the function of other AP-1 regulators, independent of c-Fos. This appears to be important for as shown in Figure 7b , the expression of c-Fos is sucient to overcome the down-regulation of AP-1 activity that accompanies calcium-induced keratinocyte dierentiation. Since many of the studies investigating the role of AP-1 activity in vitro are performed with human keratinocytes, it is tempting to assume that species dierences contribute to the dierential eects of AP-1 in mouse and human cells. However, signi®cant dierences exist between the keratinocyte serum-free medium used in the maintenance of human keratinocytes and the serumcontaining medium used for the routine culture of mouse keratinocytes. In particular, human cells are commonly cultured in a cocktail of growth factors including EGF and insulin. It is possible that under identical culture conditions, the expression of AP-1 proteins and the levels of AP-1 transcriptional activity in dierentiating human and mouse keratinocytes would be similar, the determining factor being the expression, or lack of expression, of c-Fos.
Our transcriptional assays indicate that the Fra-2/ Jun B heterodimer is a powerful negative transcriptional regulator in keratinocytes, ®ndings that are consistent with previous reports (Sonobe et al., 1995; Suzuki et al., 1991) . Down-regulation of transcriptional activity by the Fra-2/Jun B heterodimer in granular layer cells could serve a variety of purposes during the formation of normal skin. In the transition from the spinous to the granular layer, the expression of genes involved in the early stages of epidermal dierentiation must be silenced and substituted with that of genes relevant to the late stages of dierentiation. Moreover, the transition from the granular to the corni®ed layer is characterized by the replacement of live cells with enucleated mature squames consisting only of the components necessary for the formation of the corni®ed envelope. This step involves the downregulation of genes that are not relevant to cornification. The Fra-2/Jun B heterodimer may contribute to either of these, or still other processes related to the ®nal stages of epidermal dierentiation. In vivo studies will be required to establish the role of the dierent AP-1 heterodimers expressed in the distinct layers of the epidermis.
Although PKC mediates the induction of keratinocyte dierentiation by calcium as well as TPA, the pattern of marker genes expressed in response to these two stimuli is dierent, as is their eect on keratinocyte PKC isozymes (Denning et al., 1995a (Denning et al., , 1995b . Calcium-induced keratinocyte dierentiation in vitro correlates with translocation (consistent with enzyme activation) of PKCa, d and e, but not PKCZ (Denning et al., 1995a) ; in contrast, TPA activates all of these PKC isozymes (Denning et al., 1995b) . This raises the possibility that TPA-induced AP-1 activity requires stimulation of a PKC isozyme, such as PKCZ, that is not activated during calcium-induced keratinocyte dierentiation. Such isozyme-speci®c activation may in¯uence particular transcriptional regulators, with resultant changes in gene expression, to provide a mechanism by which external stimuli could in¯uence the cellular phenotype. Consistent with this idea, overexpression of PKC isozymes has recently been shown to regulate TPA-responsive promoters in an isozymespeci®c manner (Reifel-Miller et al., 1996) . The expression pattern of PKCZ in vivo suggests a function for this isozyme in the ®nal stages of epidermal dierentiation and corni®cation Osada et al., 1993) , aspects of keratinocyte dierentiation that are also induced by TPA (Lichti and Yuspa, 1988; Yuspa et al., 1982; Jetten et al., 1989) . Whether the dierences in the regulation of the ®laggrin promoter in calcium and TPA treated cells results from dierential activation of PKC isozymes remains to be determined. Nevertheless, our data clearly indicate that dierent AP-1 factors are expressed in keratinocytes in response to these two agents.
Materials and methods
Cell culture
Primary mouse keratinocytes were prepared and maintained as described previously (Hennings et al., 1980) . Brie¯y, 3610 6 freshly isolated keratinocytes were plated onto a 60 mm dish for transfection assays, and 5610 6 cells were plated per 100 mm dish for the preparation of nuclear extracts for Western blot and gel shift analysis. Cells were plated in Eagle's Minimal Essential Medium plus 8% chelex-treated fetal bovine serum containing 0.2 mM calcium, and switched to 0.05 mM calcium medium within 16 h. Dierentiation was induced by the addition of an appropriate amount of 300 mM CaCl 2 on day 6 after plating, and the cells were harvested 24 or 48 h later for the preparation of nuclear proteins. TPA-treated keratinocytes were maintained in 0.5% serum for 4 h prior to and during treatment with 162 nM TPA. Nuclear extracts were prepared 4 h later (also on day 6 after plating). The 4 h time point was found to be optimal for the induction of AP-1 DNA binding activity and c-Fos expression. No increase in AP-1 DNA binding activity was seen in calcium-treated keratinocytes 6 ± 24 h after raising the calcium concentration in the medium (Rutberg et al., 1996) .
Transfection
Primary keratinocytes were transfected on day 6 after plating using the Lipofectamine Reagent (GIBCO, Grand Island, New York). In assays using only reporter constructs, 4 mg of DNA were transfected per 60 mm dish. When a combination of reporter and expression plasmids was used, 6 mg of DNA were transfected per 60 mm dish in the ratio of 1 : 2 of reporter to expression vector. In all cases, the eects of the AP-1 expression plasmids were compared to those of the empty expression vectors (pCMV and/or pSG5) alone. Cells were transfected in serum-free, 0.05 mM calcium medium. After a 6 h transfection procedure, medium containing 0.05 or 0.12 mM calcium, or 162 nM TPA in 0.05 mM calcium was added, all in the presence of 8% chelex-treated fetal bovine serum. Cells were harvested 24, 48 or 60 h later to observe the eects of the dierent treatments, and to allow sucient time for CAT protein to be produced. Cells treated with TPA were not analysed beyond 24 h due to the rapid detachment of cells from the dishes.
CAT assays
CAT assays were performed according to the method of Neumann et al. (1987) . Three to ®ve micrograms of cellular extract were used in each reaction, and the levels of CAT activity were evaluated after a 1 h incubation at 378C. Results of the AP-1-CAT reporter assays are expressed relative to the activity of the parent pBLCAT2 plasmid to ensure that the observed activity was due only to the AP-1 DNA binding sequences on the vector (as described in Angel et al., 1987) . These experiments were replicated at least three times each. The experiments with the pro®laggrin and spr 1 constructs were also replicated at least three times, but in these cases, two separate preparations of plasmid DNA were used to minimize dierences in transfection eciency and to control for variations in the quality of the preparations of plasmid DNA.
Electrophoretic mobility shift assay (EMSA) EMSA was performed as described previously (Rutberg et al., 1996) using 3 mg of nuclear extract (Schreiber et al., 1989) per reaction. DNA binding complexes were visualized using a 32 P-labeled probe bearing a single copy of the consensus AP-1 target sequence (5'-TGAGTCA-3'). In supershift reactions, speci®c antibodies were added to the DNA binding reaction 10 min after the addition of radiolabeled probe. Competitive inhibition of DNA binding was achieved by adding unlabeled competitor DNA to the reactions 10 min prior to the addition of the radiolabeled probe. The AP-1 and SP-1 oligomers were purchased from Promega (Madison, Wisconsin).
Western blotting
Western blot analysis was performed as described previously (Rutberg et al., 1996) . The reactions presented are representative of results obtained with nuclear extracts isolated from three separate preparations of primary keratinocytes.
Plasmids and antibodies
The pBLCAT2 and 56TRE-CAT vectors (Angel et al., 1987) were obtained from M Karin (University of California at San Diego, La Jolla, California). Additional reporters containing AP-1 like sequences were generated by cloning oligomers bearing 56multimers of variations of the epidermal AP-1 sequences into the pBLCAT2 construct (see Figure 3a) . The pro®laggrin reporter constructs have been described (Jang et al., 1996) . The spr 1 reporter constructs (Reddy et al., 1996) were a gift from Reen Wu (University of California at Davis). Antibodies against cJun, Jun B, Jun D and Fra-2 were obtained from Santa Cruz Biotechnology (Santa Cruz, California). c-Fos and Fra-1 antibodies were obtained from Rodrigo Bravo (Bristol-Myers Squibb, Princeton, New Jersey), and the cFos antibody (P3) used in the supershift reactions was purchased from Caltag Laboratories (San Francisco, California). The Jun family expression vectors (pSG5c-Jun, -JunB and -JunD) were obtained from Lester Lau (University of Illinois, Chicago, Illinois), the CMV-cFos vector was a gift from Tom Curran (St Jude Children's Research Hospital, Memphis, Tennesse), and the CMVFra-2 vector was provided by Donna Cohen (The Australian University, Canberra, Australia).
